Evaluation of the anti-proliferative and anti-oxidative activities of leaf extract from in vivo and in vitro raised Ashwagandha.

[1]  Tanuj Dada,et al.  Closed chamber globe stabilization and needle capsulorhexis using irrigation hand piece of bimanual irrigation and aspiration system , 2005, BMC ophthalmology.

[2]  S. Douc-Rasy,et al.  La séquestration cytoplasmique de la protéine p53 revisitée , 2003 .

[3]  A. Kessler,et al.  High glucose promotes mesangial cell apoptosis by oxidant-dependent mechanism. , 2003, American journal of physiology. Renal physiology.

[4]  A. Izzo,et al.  Induction of nitric oxide synthase expression by Withania somnifera in macrophages. , 2003, Life sciences.

[5]  J. Olzmann,et al.  High glucose‐induced oxidative stress and mitochondrial dysfunction in neurons , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  N. Nakamura,et al.  Axon- or dendrite-predominant outgrowth induced by constituents from Ashwagandha , 2002, Neuroreport.

[7]  S. Kaul,et al.  Mortalin: a potential candidate for biotechnology and biomedicine. , 2002, Histology and histopathology.

[8]  O. Pereira-smith,et al.  Mortalin: present and prospective , 2002, Experimental Gerontology.

[9]  S. Kaul,et al.  An Hsp70 family chaperone, mortalin/mthsp70/PBP74/Grp75: what, when, and where? , 2002, Cell stress & chaperones.

[10]  N. Nakamura,et al.  Withanolide derivatives from the roots of Withania somnifera and their neurite outgrowth activities. , 2002, Chemical & pharmaceutical bulletin.

[11]  L. Davis,et al.  Effect of Withania somnifera on CTL activity. , 2002, Journal of experimental & clinical cancer research : CR.

[12]  S. Gupta,et al.  Withania somnifera Root Extract Prevents DMBA-Induced Squamous Cell Carcinoma of Skin in Swiss Albino Mice , 2002, Nutrition and cancer.

[13]  M. Furmanowa,et al.  In vitro propagation of Withania somnifera and isolation of withanolides with immunosuppressive activity. , 2001, Planta medica.

[14]  B. Sobel,et al.  High Glucose Concentrations Induce Oxidative Damage to Mitochondrial DNA in Explanted Vascular Smooth Muscle Cells , 2001, Experimental biology and medicine.

[15]  R. Reddel,et al.  Selective toxicity of MKT-077 to cancer cells is mediated by its binding to the hsp70 family protein mot-2 and reactivation of p53 function. , 2000, Cancer research.

[16]  M. A. Akbarsha,et al.  Curative property of Withania somnifera Dunal root in the context of carbendazim-induced histopathological changes in the liver and kidney of rat. , 2000, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[17]  S. Dagenais,et al.  Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. , 2000, Alternative medicine review : a journal of clinical therapeutic.

[18]  P. Scartezzini,et al.  Review on some plants of Indian traditional medicine with antioxidant activity. , 2000, Journal of ethnopharmacology.

[19]  K. Komatsu,et al.  Dendrite extension by methanol extract of Ashwagandha (roots of Withania somnifera) in SK‐N‐SH cells , 2000, Neuroreport.

[20]  J. Dhuley.  Adaptogenic and cardioprotective action of ashwagandha in rats and frogs. , 2000, Journal of ethnopharmacology.

[21]  S. Kaul,et al.  5-Bromodeoxyuridine induces senescence-like phenomena in mammalian cells regardless of cell type or species. , 1999, Journal of biochemistry.

[22]  B. Patwardhan,et al.  Studies on immunomodulatory activity of Withania somnifera (Ashwagandha) extracts in experimental immune inflammation. , 1999, Journal of ethnopharmacology.

[23]  J. R. Smith,et al.  Identification of a Gene That Reverses the Immortal Phenotype of a Subset of Cells and Is a Member of a Novel Family of Transcription Factor-Like Genes , 1999, Molecular and Cellular Biology.

[24]  A. Kar,et al.  Evidence for free radical scavenging activity of Ashwagandha root powder in mice. , 1997, Indian journal of physiology and pharmacology.

[25]  B. Fontoura,et al.  Cytoplasmic p53 polypeptide is associated with ribosomes , 1997, Molecular and cellular biology.

[26]  J. Blaydes,et al.  Evidence that transcriptional activation by p53 plays a direct role in the induction of cellular senescence. , 1996, Oncogene.

[27]  Devi Pu.  Withania somnifera Dunal (Ashwagandha): potential plant source of a promising drug for cancer chemotherapy and radiosensitization. , 1996 .

[28]  F. Wyllie,et al.  The tumour suppressor gene p53 as a regulator of proliferative life-span and tumour progression. , 1996, Biological signals.

[29]  U. Moll,et al.  Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage , 1996, Molecular and cellular biology.

[30]  J. Lehman,et al.  Increased p53 protein associated with aging in human diploid fibroblasts. , 1995, Experimental cell research.

[31]  S. Kaul,et al.  Differential subcellular distribution of mortalin in mortal and immortal mouse and human fibroblasts. , 1993, Experimental cell research.

[32]  M. al-Hindawi,et al.  Anti-granuloma activity of Iraqi Withania somnifera. , 1992, Journal of ethnopharmacology.

[33]  B. Vohra,et al.  Withania somnifera (ASHWAGANDHA) ATTENUATES ANTIOXIDANT DEFENSE IN AGED SPINAL CORD AND INHIBITS COPPER INDUCED LIPID PEROXIDATION AND PROTEIN OXIDATIVE MODIFICATIONS , 2003, Drug metabolism and drug interactions.

[34]  A. Namasivayam,et al.  Antistressor effect of Withania somnifera. , 1999, Journal of ethnopharmacology.